Apollo Hospitals Enterprise Ltd.

A price-to-earnings ratio of 62.6 against an industry average of 61.5 marks a slight premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. While the one-year return of 20.77% comfortably outpaces the Sensex’s decline of 6.32%, the short-term momentum shows a more nuanced picture with mixed performance across recent months.

A price-to-earnings ratio of 61.88 against an industry average of 60.87 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. The stock’s one-year return of 20.42% significantly outpaces the Sensex’s decline of 5.70%, yet shorter-term performance reveals a more nuanced picture.

A price-to-earnings ratio of 62.14 against an industry average of 60.05 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. While the one-year return of 21.48% comfortably outpaces the Sensex’s decline of 5.28%, the shorter-term performance reveals a more nuanced picture, with recent weeks showing some underperformance. The data presents a compelling valuation-performance tension that merits closer examination.

A price-to-earnings ratio of 61.77 against an industry average of 60.11 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. While the one-year return of 20.13% comfortably outpaces the Sensex’s decline of 5.89%, the short-term momentum shows some divergence, with a one-week loss contrasting the broader market’s gains. The data reveals a nuanced performance picture across timeframes.

A price-to-earnings ratio of 62.22 against an industry average of 60.25 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. While the one-year return of 19.57% comfortably outpaces the Sensex’s decline of 6.41%, shorter-term performance reveals a more nuanced picture, with a slight weekly dip contrasting with stronger quarterly gains. The data presents a complex valuation-performance dynamic that merits closer examination.

Apollo Hospitals Enterprise Ltd continues to consolidate its stature within the Nifty 50 index, demonstrating robust performance metrics and institutional confidence. With a recent upgrade to a Buy rating and a market capitalisation exceeding ₹1.22 lakh crores, the company’s trajectory underscores its pivotal role in the hospital sector and its influence on benchmark indices.

Apollo Hospitals Enterprise Ltd. delivered a solid weekly gain of 2.32%, outperforming the Sensex’s modest 0.57% rise from 8 to 12 June 2026. The stock hit multiple 52-week highs during the week, supported by strong derivatives market activity, robust financial metrics, and sustained technical momentum. Despite mixed broader market signals, Apollo Hospitals maintained its leadership in the hospital sector, reflecting growing investor confidence and bullish positioning ahead of the June expiry.

A price-to-earnings ratio of 62.68 against an industry average of 60.12 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. While the one-year return of 21.84% significantly outpaces the Sensex’s decline of 8.43%, the stock’s short-term momentum remains positive, with a 3-month gain of 12.51% compared to the Sensex’s negative 1.62%. The data reveals a nuanced performance across timeframes.

A price-to-earnings ratio of 62.39 against an industry average of 60.15 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. While the one-year return of 22.39% significantly outpaces the Sensex’s decline of 10.80%, the stock’s short-term momentum remains positive, defying typical sector trends. The data reveals a nuanced valuation-performance dynamic that merits closer examination.

A price-to-earnings ratio of 62.67 against an industry average of 60.36 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. The stock’s one-year return of 24.06% significantly outpaces the Sensex’s decline of 9.78%, yet the recent three-month performance shows a more tempered 9.91% gain, raising questions about momentum sustainability.

A price-to-earnings ratio of 61.41 against an industry average of 59.90 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. Over the past year, the stock has delivered a robust 21.24% return, comfortably outperforming the Sensex’s decline of 10.42%, yet the data reveals nuanced shifts in momentum across shorter timeframes.

A price-to-earnings ratio of 61.01 against an industry average of 59.50 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 11 May 2026. The stock’s one-year return of 19.50% significantly outpaces the Sensex’s negative 10.58%, yet the short-term momentum remains mixed, presenting a nuanced picture of performance and valuation.